For patients diagnosed with HR-positive, HER2-negative breast cancer, treatment is often not a single drug but a carefully designed strategy. Among the most important advances

Pulmonary hypertension (PH) is a progressive and potentially life-threatening condition characterized by persistently elevated pressure in the pulmonary circulation. ⚠️ Early symptoms—such as shortness of

In China, chronic hepatitis B remains a major public health challenge, affecting tens of millions of people. 😖 For patients who require long-term antiviral therapy,

As global demographic shifts, evolving disease landscapes, and rising expectations for treatment experience continue to reshape healthcare, the pharmaceutical industry is facing unprecedented opportunities and

In the field of oncology, relapsed or refractory peripheral T-cell lymphoma (PTCL) and endocrine therapy resistance in HR-positive advanced breast cancer remain two major clinical

The treatment of advanced gastrointestinal stromal tumors (GIST) is a long and arduous race against genetic mutations. 💊 Patients typically follow a standard sequential treatment